Back
Mineralys Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
MLYS
Mineralys Therapeutics, Inc.
Last Price:
$36.85
Seasonality Move:
41.51%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLYS is experiencing slight selling pressure.
Mineralys Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.51 | Buy |
| 20-day SMA: | 38.83 | Sell |
| 50-day SMA: | 40.75 | Sell |
| 200-day SMA: | 24.23 | Buy |
| 8-day EMA: | 36.97 | Sell |
| 20-day EMA: | 38.3 | Sell |
| 50-day EMA: | 38.42 | Sell |
| 200-day EMA: | 27.73 | Buy |
Mineralys Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.28 | Sell |
| Relative Strength Index (14 RSI): | 40.71 | Sell |
| Chaikin Money Flow: | -2506788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.83 - 42.31) | Sell |
| Bollinger Bands (100): | (23.08 - 44.84) | Buy |
Mineralys Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mineralys Therapeutics, Inc. Stock
Is Mineralys Therapeutics, Inc. Stock a Buy?
-
Mineralys Therapeutics, Inc. share price is 36.83 while MLYS 8-day simple moving average is 36.51, which is a Buy signal.
-
The stock price of MLYS is 36.83 while Mineralys Therapeutics, Inc. 20-day SMA is 38.83, which makes it a Sell.
-
Mineralys Therapeutics, Inc. 50-day simple moving average is 40.75 while MLYS share price is 36.83, making it a Sell technically.
-
MLYS stock price is 36.83 and Mineralys Therapeutics, Inc. 200-day simple moving average is 24.23, creating a Buy signal.
MLYS Technical Analysis vs Fundamental Analysis
Sell
39
Mineralys Therapeutics, Inc. (MLYS)
is a Sell
Is Mineralys Therapeutics, Inc. a Buy or a Sell?
-
Mineralys Therapeutics, Inc. stock is rated a SellThe current Mineralys Therapeutics, Inc. [MLYS] share price is $36.83. The Score for MLYS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Mineralys Therapeutics, Inc. Stock Info
Market Cap:
2.9B
Price in USD:
36.83
Share Volume:
6.2M
Mineralys Therapeutics, Inc. 52-Week Range
52-Week High:
47.65
52-Week Low:
8.24
Sell
39
Mineralys Therapeutics, Inc. (MLYS)
is a Sell
Mineralys Therapeutics, Inc. Share Price Forecast
-
What is the Mineralys Therapeutics, Inc. stock price today?The Mineralys Therapeutics, Inc. stock price is 36.83 USD today.
-
Will MLYS stock go up or go down?Mineralys Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Mineralys Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mineralys Therapeutics, Inc. is overvalued.
Is Mineralys Therapeutics, Inc. Stock a Buy?
-
Mineralys Therapeutics, Inc. share price is 36.83 while MLYS 8-day exponential moving average is 36.97, which is a Sell signal.
-
The stock price of MLYS is 36.83 while Mineralys Therapeutics, Inc. 20-day EMA is 38.30, which makes it a Sell.
-
Mineralys Therapeutics, Inc. 50-day exponential moving average is 38.42 while MLYS share price is 36.83, making it a Sell technically.
-
MLYS stock price is 36.83 and Mineralys Therapeutics, Inc. 200-day simple moving average is 27.73, creating a Buy signal.
Fundamental Analysis of Mineralys Therapeutics, Inc.
Is Mineralys Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.28 per share, and an increase next year of $0.06 per share.
Technical Analysis of Mineralys Therapeutics, Inc.
Should I short Mineralys Therapeutics, Inc. stock?
-
MLYS Moving Average Covergence Divergence (MACD) indicator is -1.28, suggesting Mineralys Therapeutics, Inc. is a Sell
-
Mineralys Therapeutics, Inc. Relative Strength Index (RSI) is 40.71, which suggest Mineralys Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Mineralys Therapeutics, Inc. is (36.83 - 42.31), which suggest Mineralys Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Mineralys Therapeutics, Inc. is (23.08 - 44.84), which suggest Mineralys Therapeutics, Inc. is a Buy
* Mineralys Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.